TGTX
TG Therapeutics
获取预测
在您的设备上获取AI股票预测
关于该公司
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.
立即获取AI股票预测
下载我们的AI股票预测实时应用
